US Stock MarketDetailed Quotes

MDNAF Medicenna Therapeutics

Watchlist
  • 1.410
  • +0.015+1.08%
15min DelayClose Jul 19 16:00 ET
105.44MMarket Cap-8392P/E (TTM)

Medicenna Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
(FY)Mar 31, 2022
(Q4)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-39.82%21.76M
-35.80%25.69M
53.42%29.62M
63.60%33.6M
63.60%33.6M
54.55%36.15M
49.91%40.01M
-46.24%19.3M
-49.15%20.54M
-49.15%20.54M
-Cash and cash equivalents
-39.82%21.76M
-35.80%25.69M
53.42%29.62M
63.60%33.6M
63.60%33.6M
54.55%36.15M
139.73%40.01M
-25.49%19.3M
-32.40%20.54M
-32.40%20.54M
Receivables
125.14%403K
105.37%306K
788.30%835K
-34.63%855K
-34.63%855K
-70.36%179K
-65.35%149K
-89.65%94K
219.02%1.31M
219.02%1.31M
-Taxes receivable
----
----
----
-34.63%855K
-34.63%855K
----
----
----
219.02%1.31M
219.02%1.31M
-Other receivables
125.14%403K
105.37%306K
788.30%835K
----
----
-70.36%179K
-65.35%149K
-89.65%94K
----
----
Prepaid assets
-41.07%1.05M
-27.70%1.69M
52.80%1.04M
24.94%1.93M
24.94%1.93M
-12.66%1.78M
-19.09%2.34M
58.41%678K
14.33%1.55M
14.33%1.55M
Total current assets
-39.10%23.21M
-34.86%27.68M
56.84%31.49M
55.55%36.39M
55.55%36.39M
46.39%38.11M
41.61%42.5M
-46.10%20.08M
-44.50%23.39M
-44.50%23.39M
Non current assets
Goodwill and other intangible assets
-6.45%58K
-6.35%59K
-7.69%60K
-6.15%61K
-6.15%61K
-8.82%62K
-8.70%63K
-7.14%65K
-8.45%65K
-8.45%65K
-Other intangible assets
----
--59K
--60K
----
----
----
----
----
----
----
Total non current assets
-6.45%58K
-6.35%59K
-7.69%60K
-6.15%61K
-6.15%61K
-15.07%62K
-24.10%63K
-30.11%65K
-36.89%65K
-36.89%65K
Total assets
-39.05%23.27M
-34.81%27.74M
56.63%31.55M
55.38%36.45M
55.38%36.45M
46.22%38.17M
41.43%42.56M
-46.06%20.14M
-44.49%23.46M
-44.49%23.46M
Liabilities
Current liabilities
Payables
----
----
----
-3.29%1.62M
-3.29%1.62M
----
----
----
-25.52%1.67M
-25.52%1.67M
-accounts payable
----
----
----
-3.29%1.62M
-3.29%1.62M
----
----
----
-25.52%1.67M
-25.52%1.67M
Current accrued expenses
----
----
----
130.03%2.18M
130.03%2.18M
----
----
----
-48.09%949K
-48.09%949K
Current liabilities
34.69%4.03M
25.81%3.7M
50.58%3.23M
44.98%3.8M
44.98%3.8M
27.14%2.99M
-45.92%2.94M
-56.70%2.15M
-36.18%2.62M
-36.18%2.62M
Non current liabilities
Derivative product liabilities
-68.72%613K
-92.06%453K
--1.41M
--3.16M
--3.16M
--1.96M
--5.71M
----
--0
--0
Other non current liabilities
----
--158K
----
----
----
----
----
----
----
----
Total non current liabilities
-68.72%613K
-89.29%611K
--1.41M
--3.16M
--3.16M
--1.96M
--5.71M
--0
--0
--0
Total liabilities
-6.26%4.64M
-50.19%4.31M
116.39%4.65M
165.55%6.96M
165.55%6.96M
110.51%4.95M
59.16%8.64M
-56.70%2.15M
-36.18%2.62M
-36.18%2.62M
Shareholders'equity
Share capital
0.00%100.92M
-0.05%100.92M
19.24%100.92M
20.62%100.92M
20.62%100.92M
20.76%100.92M
26.10%100.98M
5.91%84.64M
5.13%83.67M
5.13%83.67M
-common stock
0.00%100.92M
-0.05%100.92M
19.24%100.92M
20.62%100.92M
20.62%100.92M
20.76%100.92M
26.10%100.98M
5.91%84.64M
5.13%83.67M
5.13%83.67M
Retained earnings
-19.99%-92.54M
-15.24%-87.57M
-11.66%-83.84M
-14.17%-80.98M
-14.17%-80.98M
-13.88%-77.13M
-20.76%-75.98M
-37.17%-75.09M
-46.69%-70.93M
-46.69%-70.93M
Paid-in capital
9.86%10.21M
14.68%10.05M
17.39%9.78M
19.68%9.49M
19.68%9.49M
20.74%9.29M
20.26%8.76M
19.45%8.33M
18.65%7.93M
18.65%7.93M
Gains losses not affecting retained earnings
-70.15%40K
-81.25%30K
-65.74%37K
-66.67%57K
-66.67%57K
-37.96%134K
-27.27%160K
-53.04%108K
-26.92%171K
-26.92%171K
Total stockholders'equity
-43.93%18.63M
-30.90%23.44M
49.50%26.9M
41.52%29.49M
41.52%29.49M
39.86%33.23M
37.52%33.92M
-44.43%17.99M
-45.38%20.84M
-45.38%20.84M
Total equity
-43.93%18.63M
-30.90%23.44M
49.50%26.9M
41.52%29.49M
41.52%29.49M
39.86%33.23M
37.52%33.92M
-44.43%17.99M
-45.38%20.84M
-45.38%20.84M
Currency Unit
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022(FY)Mar 31, 2022(Q4)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -39.82%21.76M-35.80%25.69M53.42%29.62M63.60%33.6M63.60%33.6M54.55%36.15M49.91%40.01M-46.24%19.3M-49.15%20.54M-49.15%20.54M
-Cash and cash equivalents -39.82%21.76M-35.80%25.69M53.42%29.62M63.60%33.6M63.60%33.6M54.55%36.15M139.73%40.01M-25.49%19.3M-32.40%20.54M-32.40%20.54M
Receivables 125.14%403K105.37%306K788.30%835K-34.63%855K-34.63%855K-70.36%179K-65.35%149K-89.65%94K219.02%1.31M219.02%1.31M
-Taxes receivable -------------34.63%855K-34.63%855K------------219.02%1.31M219.02%1.31M
-Other receivables 125.14%403K105.37%306K788.30%835K---------70.36%179K-65.35%149K-89.65%94K--------
Prepaid assets -41.07%1.05M-27.70%1.69M52.80%1.04M24.94%1.93M24.94%1.93M-12.66%1.78M-19.09%2.34M58.41%678K14.33%1.55M14.33%1.55M
Total current assets -39.10%23.21M-34.86%27.68M56.84%31.49M55.55%36.39M55.55%36.39M46.39%38.11M41.61%42.5M-46.10%20.08M-44.50%23.39M-44.50%23.39M
Non current assets
Goodwill and other intangible assets -6.45%58K-6.35%59K-7.69%60K-6.15%61K-6.15%61K-8.82%62K-8.70%63K-7.14%65K-8.45%65K-8.45%65K
-Other intangible assets ------59K--60K----------------------------
Total non current assets -6.45%58K-6.35%59K-7.69%60K-6.15%61K-6.15%61K-15.07%62K-24.10%63K-30.11%65K-36.89%65K-36.89%65K
Total assets -39.05%23.27M-34.81%27.74M56.63%31.55M55.38%36.45M55.38%36.45M46.22%38.17M41.43%42.56M-46.06%20.14M-44.49%23.46M-44.49%23.46M
Liabilities
Current liabilities
Payables -------------3.29%1.62M-3.29%1.62M-------------25.52%1.67M-25.52%1.67M
-accounts payable -------------3.29%1.62M-3.29%1.62M-------------25.52%1.67M-25.52%1.67M
Current accrued expenses ------------130.03%2.18M130.03%2.18M-------------48.09%949K-48.09%949K
Current liabilities 34.69%4.03M25.81%3.7M50.58%3.23M44.98%3.8M44.98%3.8M27.14%2.99M-45.92%2.94M-56.70%2.15M-36.18%2.62M-36.18%2.62M
Non current liabilities
Derivative product liabilities -68.72%613K-92.06%453K--1.41M--3.16M--3.16M--1.96M--5.71M------0--0
Other non current liabilities ------158K--------------------------------
Total non current liabilities -68.72%613K-89.29%611K--1.41M--3.16M--3.16M--1.96M--5.71M--0--0--0
Total liabilities -6.26%4.64M-50.19%4.31M116.39%4.65M165.55%6.96M165.55%6.96M110.51%4.95M59.16%8.64M-56.70%2.15M-36.18%2.62M-36.18%2.62M
Shareholders'equity
Share capital 0.00%100.92M-0.05%100.92M19.24%100.92M20.62%100.92M20.62%100.92M20.76%100.92M26.10%100.98M5.91%84.64M5.13%83.67M5.13%83.67M
-common stock 0.00%100.92M-0.05%100.92M19.24%100.92M20.62%100.92M20.62%100.92M20.76%100.92M26.10%100.98M5.91%84.64M5.13%83.67M5.13%83.67M
Retained earnings -19.99%-92.54M-15.24%-87.57M-11.66%-83.84M-14.17%-80.98M-14.17%-80.98M-13.88%-77.13M-20.76%-75.98M-37.17%-75.09M-46.69%-70.93M-46.69%-70.93M
Paid-in capital 9.86%10.21M14.68%10.05M17.39%9.78M19.68%9.49M19.68%9.49M20.74%9.29M20.26%8.76M19.45%8.33M18.65%7.93M18.65%7.93M
Gains losses not affecting retained earnings -70.15%40K-81.25%30K-65.74%37K-66.67%57K-66.67%57K-37.96%134K-27.27%160K-53.04%108K-26.92%171K-26.92%171K
Total stockholders'equity -43.93%18.63M-30.90%23.44M49.50%26.9M41.52%29.49M41.52%29.49M39.86%33.23M37.52%33.92M-44.43%17.99M-45.38%20.84M-45.38%20.84M
Total equity -43.93%18.63M-30.90%23.44M49.50%26.9M41.52%29.49M41.52%29.49M39.86%33.23M37.52%33.92M-44.43%17.99M-45.38%20.84M-45.38%20.84M
Currency Unit CADCADCADCADCADCADCADCADCADCAD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg